NYSE - Delayed Quote USD

ResMed Inc. (RMD)

Time to buy RMD?
246.99
-0.66
(-0.27%)
At close: May 14 at 4:00:02 PM EDT
247.00
+0.01
+(0.00%)
Pre-Market: 4:09:32 AM EDT
Time to buy RMD?
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
5,021,529
4,685,297
4,222,993
3,578,127
3,196,825
Cost of Revenue
2,071,100
2,029,994
1,867,331
1,553,816
1,357,725
Gross Profit
2,950,429
2,655,303
2,355,662
2,024,311
1,839,100
Operating Expense
1,338,390
1,271,182
1,203,665
1,022,161
926,749
Operating Income
1,612,039
1,384,121
1,151,997
1,002,150
912,351
Net Non Operating Interest Income Expense
-7,564
-45,708
-47,379
-22,312
-23,627
Other Income Expense
-27,230
-73,615
-2,954
-19,355
-5,062
Pretax Income
1,577,245
1,264,798
1,101,664
960,483
883,662
Tax Provision
263,991
243,847
204,108
181,046
409,157
Net Income Common Stockholders
1,313,254
1,020,951
897,556
779,437
474,505
Diluted NI Available to Com Stockholders
1,313,254
1,020,951
897,556
779,437
474,505
Basic EPS
8.94
6.94
6.12
5.34
3.27
Diluted EPS
8.91
6.92
6.09
5.30
3.24
Basic Average Shares
146,826.75
147,021
146,765
146,066
145,313
Diluted Average Shares
147,462.25
147,550
147,455
147,043
146,451
Total Operating Income as Reported
1,612,039
1,319,893
1,131,871
1,000,286
903,678
Total Expenses
3,409,490
3,301,176
3,070,996
2,575,977
2,284,474
Net Income from Continuing & Discontinued Operation
1,313,254
1,020,951
897,556
779,437
474,505
Normalized Income
1,313,254
1,072,783
897,473.69
780,950.57
480,836.29
Interest Income
--
--
--
--
362
Interest Expense
--
45,708
47,379
22,312
23,989
Net Interest Income
-7,564
-45,708
-47,379
-22,312
-23,627
EBIT
1,538,424
1,310,506
1,149,043
982,795
912,351
EBITDA
1,754,702
1,526,715
1,346,605
1,176,636
1,103,869
Reconciled Cost of Revenue
1,899,429
1,860,306
1,711,789
1,391,053
1,197,285
Reconciled Depreciation
216,278
216,209
197,562
193,841
191,518
Net Income from Continuing Operation Net Minority Interest
1,313,254
1,020,951
897,556
779,437
474,505
Total Unusual Items Excluding Goodwill
0
-64,228
101
-1,864
-8,673
Total Unusual Items
0
-64,228
101
-1,864
-8,673
Normalized EBITDA
1,754,702
1,590,943
1,346,504
1,178,500
1,112,542
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-12,396
18.69
-350.43
-2,341.71
6/30/2021 - 6/2/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
80.47
-1.58%
 
WST West Pharmaceutical Services, Inc.
206.69
-4.25%
 
ALC Alcon Inc.
87.24
-6.11%
 
ALGN Align Technology, Inc.
187.65
-1.45%
 
RGEN Repligen Corporation
128.04
-2.67%
 
HOLX Hologic, Inc.
55.36
-3.08%
 
ATR AptarGroup, Inc.
152.48
-0.76%
 
BAX Baxter International Inc.
30.32
-2.66%
 
BDX Becton, Dickinson and Company
171.02
-2.46%
 
ICUI ICU Medical, Inc.
135.93
-5.33%